Published in Vector Borne Zoonotic Dis on January 01, 2006
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog (2007) 10.38
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One (2009) 2.22
Chikungunya virus arthritis in adult wild-type mice. J Virol (2010) 2.16
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog (2011) 1.95
Chimeric alphavirus vaccine candidates for chikungunya. Vaccine (2008) 1.78
Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog (2011) 1.62
Replication cycle of chikungunya: a re-emerging arbovirus. Virology (2009) 1.61
In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol (2013) 1.59
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress. Cell (2015) 1.58
The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus (2008) 1.53
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A (2012) 1.48
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog (2013) 1.47
Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLoS Pathog (2015) 1.43
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis (2012) 1.42
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One (2011) 1.37
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff. J Virol (2010) 1.27
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis (2010) 1.23
Viperin restricts chikungunya virus replication and pathology. J Clin Invest (2012) 1.16
Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One (2010) 1.16
Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. J Infect Dis (2014) 1.15
Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One (2010) 1.09
Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology (2009) 1.08
Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish. PLoS Pathog (2013) 1.06
Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J Virol (2013) 1.05
Chikungunya virus 3' untranslated region: adaptation to mosquitoes and a population bottleneck as major evolutionary forces. PLoS Pathog (2013) 1.04
Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis (2014) 1.02
Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. PLoS Pathog (2014) 0.95
Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes. J Virol (2014) 0.90
Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells. PLoS Pathog (2013) 0.90
Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol J (2011) 0.87
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration. Cell Host Microbe (2016) 0.86
Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol (2014) 0.86
Evaluation of Simultaneous Transmission of Chikungunya Virus and Dengue Virus Type 2 in Infected Aedes aegypti and Aedes albopictus (Diptera: Culicidae). J Med Entomol (2015) 0.84
A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation. PLoS Negl Trop Dis (2015) 0.84
Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PLoS One (2013) 0.84
Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol (2008) 0.83
The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses. J Virol (2016) 0.82
Properties and use of novel replication-competent vectors based on Semliki Forest virus. Virol J (2009) 0.82
Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library. PLoS Negl Trop Dis (2013) 0.82
In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone. Vector Borne Zoonotic Dis (2011) 0.82
Eilat virus displays a narrow mosquito vector range. Parasit Vectors (2014) 0.81
Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation. J Neurovirol (2015) 0.81
Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice. J Virol (2013) 0.81
Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus. Am J Trop Med Hyg (2011) 0.80
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med (2014) 0.80
Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. J Virol (2013) 0.79
Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity. J Virol (2015) 0.79
Discovery of mosquito saliva microRNAs during CHIKV infection. PLoS Negl Trop Dis (2015) 0.79
Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus. PLoS One (2011) 0.79
Eilat virus induces both homologous and heterologous interference. Virology (2015) 0.78
Infection of Aedes albopictus with chikungunya virus rectally administered by enema. Vector Borne Zoonotic Dis (2012) 0.78
pH-Dependent entry of chikungunya virus fusion into mosquito cells. Virol J (2014) 0.77
Development of Neutralization Assay Using an eGFP Chikungunya Virus. Viruses (2016) 0.77
The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling. J Virol (2016) 0.77
Development of infectious cDNA clones of Salmonid alphavirus subtype 3. BMC Res Notes (2010) 0.76
Subgenomic reporter RNA system for detection of alphavirus infection in mosquitoes. PLoS One (2013) 0.76
Chikungunya vaccines in development. Hum Vaccin Immunother (2016) 0.76
Detection of Persistent Chikungunya Virus RNA but not Infectious Virus in Experimental Vertical Transmission in Aedes aegypti from Malaysia. Am J Trop Med Hyg (2015) 0.76
Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Res (2014) 0.75
Imaging of viral neuroinvasion in the zebrafish reveals that Sindbis and chikungunya viruses favour different entry routes. Dis Model Mech (2017) 0.75
A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog (2007) 10.38
West Nile virus: where are we now? Lancet Infect Dis (2004) 3.49
Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J (2008) 3.39
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
Sequencing of Culex quinquefasciatus establishes a platform for mosquito comparative genomics. Science (2010) 3.18
A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med (2003) 2.89
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology (2003) 2.59
Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol (2005) 2.52
Sequences of flavivirus-related RNA viruses persist in DNA form integrated in the genome of Aedes spp. mosquitoes. J Gen Virol (2004) 2.37
Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One (2009) 2.22
Chikungunya virus arthritis in adult wild-type mice. J Virol (2010) 2.16
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg (2004) 2.02
Climate-based models for understanding and forecasting dengue epidemics. PLoS Negl Trop Dis (2012) 2.01
Concurrent dengue and malaria. Emerg Infect Dis (2005) 1.98
Yellow fever: a disease that has yet to be conquered. Annu Rev Entomol (2007) 1.94
The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans R Soc Trop Med Hyg (2008) 1.88
An immune-responsive serpin, SRPN6, mediates mosquito defense against malaria parasites. Proc Natl Acad Sci U S A (2005) 1.87
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Impact of Wolbachia on infection with chikungunya and yellow fever viruses in the mosquito vector Aedes aegypti. PLoS Negl Trop Dis (2012) 1.72
High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One (2010) 1.68
Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunol (2006) 1.62
Replication cycle of chikungunya: a re-emerging arbovirus. Virology (2009) 1.61
Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus. Am J Trop Med Hyg (2004) 1.60
Identification of microRNAs expressed in two mosquito vectors, Aedes albopictus and Culex quinquefasciatus. BMC Genomics (2010) 1.59
LARVAL COMPETITION DIFFERENTIALLY AFFECTS ARBOVIRUS INFECTION IN AEDES MOSQUITOES. Ecology (2005) 1.58
Pathogenomics of Culex quinquefasciatus and meta-analysis of infection responses to diverse pathogens. Science (2010) 1.58
trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J Virol (2004) 1.57
Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J Virol (2010) 1.55
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology (2006) 1.54
West Nile virus dissemination and tissue tropisms in orally infected Culex pipiens quinquefasciatus. Vector Borne Zoonotic Dis (2004) 1.51
The 2005-2006 Chikungunya epidemic in the Indian Ocean. Vector Borne Zoonotic Dis (2006) 1.50
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine (2009) 1.48
Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect Biochem Mol Biol (2005) 1.45
Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection. Viral Immunol (2004) 1.44
Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg (2011) 1.42
"Megavirales", a proposed new order for eukaryotic nucleocytoplasmic large DNA viruses. Arch Virol (2013) 1.41
Ultrastructural study of West Nile virus pathogenesis in Culex pipiens quinquefasciatus (Diptera: Culicidae). J Med Entomol (2005) 1.39
RNA interference-mediated knockdown of a GATA factor reveals a link to anautogeny in the mosquito Aedes aegypti. Proc Natl Acad Sci U S A (2003) 1.36
Dengue 1 diversity and microevolution, French Polynesia 2001-2006: connection with epidemiology and clinics. PLoS Negl Trop Dis (2009) 1.32
Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg (2005) 1.30
Year-round West Nile virus activity, Gulf Coast region, Texas and Louisiana. Emerg Infect Dis (2004) 1.28
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes. J Infect Dis (2008) 1.23
Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis (2010) 1.23
Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates. J Infect Dis (2008) 1.23
Alterations in the Aedes aegypti transcriptome during infection with West Nile, dengue and yellow fever viruses. PLoS Pathog (2011) 1.22
Nonviremic transmission of West Nile virus. Proc Natl Acad Sci U S A (2005) 1.22
Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One (2007) 1.21
Anopheles gambiae heat shock protein cognate 70B impedes o'nyong-nyong virus replication. BMC Genomics (2007) 1.20
Punique virus, a novel phlebovirus, related to sandfly fever Naples virus, isolated from sandflies collected in Tunisia. J Gen Virol (2010) 1.19
Salivary gland morphology and virus transmission during long-term cytopathologic West Nile virus infection in Culex mosquitoes. Am J Trop Med Hyg (2007) 1.19
Evaluation of the function of a type I peritrophic matrix as a physical barrier for midgut epithelium invasion by mosquito-borne pathogens in Aedes aegypti. Vector Borne Zoonotic Dis (2008) 1.17
Potential arbovirus emergence and implications for the United Kingdom. Emerg Infect Dis (2006) 1.17
Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One (2010) 1.16
A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis (2002) 1.16
Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. J Gen Virol (2006) 1.16
Dengue virus type 3 infection in traveler returning from west Africa. Emerg Infect Dis (2009) 1.12
Sheep-to-human transmission of Orf virus during Eid al-Adha religious practices, France. Emerg Infect Dis (2013) 1.12
Natural host relationships and genetic diversity of Whitewater Arroyo virus in southern Texas. Am J Trop Med Hyg (2002) 1.12
Likely correlation between sources of information and acceptability of A/H1N1 swine-origin influenza virus vaccine in Marseille, France. PLoS One (2010) 1.12
Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One (2010) 1.09
Alkhurma haemorrhagic fever--a viral haemorrhagic disease unique to the Arabian Peninsula. Int J Antimicrob Agents (2010) 1.07
Dual infection by dengue virus and Shigella sonnei in patient returning from India. Emerg Infect Dis (2003) 1.06
Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06
Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J Immunol (2003) 1.04
Transcriptome changes in Culex quinquefasciatus (Diptera: Culicidae) salivary glands during West Nile virus infection. J Med Entomol (2010) 1.04
Cowpox virus transmission from pet rats to humans, France. Emerg Infect Dis (2009) 1.04
Oral transmission of West Nile virus in a hamster model. Am J Trop Med Hyg (2005) 1.03
Coordinated implementation of chikungunya virus reverse transcription-PCR. Emerg Infect Dis (2009) 1.03
Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand. Am J Trop Med Hyg (2006) 1.02
Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection. PLoS One (2010) 1.02
Isolation of Toscana virus from the cerebrospinal fluid of a man with meningitis in Marseille, France, 2010. Vector Borne Zoonotic Dis (2013) 1.02
Toscana virus isolated from sandflies, Tunisia. Emerg Infect Dis (2013) 1.00
Flavivirus RNA in phlebotomine sandflies. Vector Borne Zoonotic Dis (2010) 0.99
Viruses of the family Bunyaviridae: are all available isolates reassortants? Virology (2013) 0.99